Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 48, 2018 - Issue 7
384
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Design and synthesis of fluorescent symmetric bis-triazolylated-1,4-dihydropyridines as potent antibreast cancer agents

, , , , , & show all
Pages 778-785 | Received 03 Nov 2017, Published online: 13 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (12)

Ashruba B. Danne, Krishna V. Lathi, Jaiprakash N. Sangshetti, Vijay M. Khedkar, Laxman D. Khalse & Bapurao B. Shingate. (2024) New 1,2,3-triazole tethered-1,4-dihydropyridines as potential antioxidant agents: Synthesis and molecular docking study. Journal of Molecular Structure 1299, pages 137129.
Crossref
Santha Kumari Merugu, V. B. R. Krishnan K, Ravi Kumar K, Siddique Akber Ansari, Irfan Aamer Ansari & Hari Babu Bollikolla. (2023) Synthesis, Anticancer Evaluation and in Silico Studies of 1,4‐Dihydropyridines . Chemistry & Biodiversity.
Crossref
Miyase Gözde Gündüz, Cagatay Dengiz, Ebru Koçak Aslan, Sanja Skaro Bogojevic & Jasmina Nikodinovic-Runic. (2022) Attaching azoles to Hantzsch 1,4-dihydropyridines: Synthesis, theoretical investigation of nonlinear optical properties, antimicrobial evaluation and molecular docking studies. Journal of Molecular Structure 1247, pages 131316.
Crossref
Alimamad Malani, Atul Makwana, Jahnvi Monapara, Iqrar Ahmad, Harun Patel & Nisheeth Desai. (2021) Synthesis, molecular docking, DFT study, and in vitro antimicrobial activity of some 4‐(biphenyl‐4‐yl)‐1,4‐dihydropyridine and 4‐(biphenyl‐4‐yl)pyridine derivatives. Journal of Biochemical and Molecular Toxicology 35:11.
Crossref
Yahya Nural, Sadin Ozdemir, Mustafa Serkan Yalcin, Bunyamin Demir, Hasan Atabey, Abdulilah Ece & Zeynel Seferoglu. (2021) Synthesis, Biological Evaluation, Molecular Docking, and Acid Dissociation Constant of New Bis‐1,2,3‐triazole Compounds. ChemistrySelect 6:28, pages 6994-7001.
Crossref
Valeriia Hutskalova & Christof Sparr. (2021) Ad Hoc Adjustment of Photoredox Properties by the Late-Stage Diversification of Acridinium Photocatalysts. Organic Letters 23:13, pages 5143-5147.
Crossref
Nidhi Deswal, Ankita Shrivastava, Md. Summon Hossain, Parveen Gahlyan, Rashim Bawa, Rinkoo Devi Gupta & Rakesh Kumar. (2021) Design, Synthesis, Evaluation and Molecular Docking Studies of Novel Triazole Linked 1,4‐Dihydropyridine‐isatin Scaffolds as Potent Anticancer Agents. ChemistrySelect 6:4, pages 717-725.
Crossref
Rakesh Kumar, Neha Yadav, Ankita Leekha, Rashim Bawa, Parveen Gahlyan, Mamta Bhandari, Ritu Arora, Anita Kamra Verma & Rita Kakkar. (2021) Novel 1‐Triazolylpyranopyrazoles as Highly Potent Anticancer Agents Obtained via MW‐Assisted Synthesis . ChemistrySelect 6:4, pages 589-594.
Crossref
Larry Yet. 2020. 325 361 .
Zhi Xu, Shi-Jia Zhao & Yi Liu. (2019) 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. European Journal of Medicinal Chemistry 183, pages 111700.
Crossref
Abhinav Prasoon Mishra, Ankit Bajpai & Awani Kumar Rai. (2019) 1,4-Dihydropyridine: A Dependable Heterocyclic Ring with the Promising and the Most Anticipable Therapeutic Effects. Mini-Reviews in Medicinal Chemistry 19:15, pages 1219-1254.
Crossref
Rakesh Kumar, Rashim Bawa, Parveen Gahlyan, Manu Dalela, Kajal Jindal, Pradip K. Jha, Monika Tomar & Vinay Gupta. (2019) Pyrene appended bis-triazolylated 1,4-dihydropyridine as a selective fluorogenic sensor for Cu2+. Dyes and Pigments 161, pages 162-171.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.